Related references
Note: Only part of the references are listed.Galectin-3 in Ambulatory Patients With Heart Failure Results From the HF-ACTION Study
G. Michael Felker et al.
CIRCULATION-HEART FAILURE (2012)
Emerging Biomarkers in Heart Failure
Roland R. J. van Kimmenade et al.
CLINICAL CHEMISTRY (2012)
Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure
Antoni Bayes-Genis et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure
Wayne L. Miller et al.
HEART (2012)
Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and Survival
W. H. Wilson Tang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
Rudolf A. de Boer et al.
ANNALS OF MEDICINE (2011)
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
U. Wallin et al.
BRITISH JOURNAL OF CANCER (2011)
Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study
Justin T. Saunders et al.
CIRCULATION (2011)
High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart Failure
Bonnie Ky et al.
CIRCULATION-HEART FAILURE (2011)
Determining Decision Limits for New Biomarkers: Clinical and Statistical Considerations
David A. Morrow et al.
CLINICAL CHEMISTRY (2011)
Systems biology of heart failure, challenges and hopes
Frederick E. Dewey et al.
CURRENT OPINION IN CARDIOLOGY (2011)
Clinical outcome of renal tubular damage in chronic heart failure
Kevin Damman et al.
EUROPEAN HEART JOURNAL (2011)
Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses
Andrew Jabbour et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure
Ioannis Tentzeris et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Growth-differentiation factor 15 as predictor of mortality in acute reperfused ST-elevation myocardial infarction: insights from cardiovascular magnetic resonance
Ingo Eitel et al.
HEART (2011)
Galectin-3 in heart failure: high levels are associated with all-cause mortality
Thor Ueland et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Association of Copeptin and N-Terminal proBNP Concentrations With Risk of Cardiovascular Death in Older Patients With Symptoms of Heart Failure
Urban Alehagen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Neuregulin-1β for the treatment of systolic heart failure
Douglas B. Sawyer et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Volume Status and Diuretic Therapy in Systolic Heart Failure and the Detection of Early Abnormalities in Renal and Tubular Function
Kevin Damman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice
Tibor Kempf et al.
NATURE MEDICINE (2011)
Identification of Chronic Heart Failure Patients with a High 12-Month Mortality Risk Using Biomarkers Including Plasma C-Terminal Pro-Endothelin-1
Ewa A. Jankowska et al.
PLOS ONE (2011)
Multimarker approach for heart failure management: Perspectives and limitations
Daniela Giannessi
PHARMACOLOGICAL RESEARCH (2011)
Biomarkers as Surrogate End Points in Heart Failure Trials
G. Michael Felker
HEART FAILURE CLINICS (2011)
Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study
Anju Bhardwaj et al.
AMERICAN HEART JOURNAL (2010)
Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure
Takayoshi Tsutamoto et al.
AMERICAN HEART JOURNAL (2010)
Novel biomarkers in cardiovascular disease: Update 2010
Willibald Hochholzer et al.
AMERICAN HEART JOURNAL (2010)
Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure Relation to Disease Severity and Prognosis in the Valsartan Heart Failure Trial
Inder S. Anand et al.
CIRCULATION (2010)
Heart Disease and Stroke Statistics-2010 Update A Report From the American Heart Association
Donald Lloyd-Jones et al.
CIRCULATION (2010)
Growth- Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non-ST-Segment-Elevation Acute Coronary Syndrome
Kai M. Eggers et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Prognostic Value of Emerging Neurohormones in Chronic Heart Failure during Optimization of Heart Failure-Specific Therapy
Stephanie Neuhold et al.
CLINICAL CHEMISTRY (2010)
Prognostic Assessment of Elderly Patients with Symptoms of Heart Failure by Combining High-Sensitivity Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide Measurements
Urban Alehagen et al.
CLINICAL CHEMISTRY (2010)
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
Dirk J. A. Lok et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology
D. Bolignano et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial
Serge Masson et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure
Stephan von Haehling et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure
Ravi V. Shah et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Biomarker guided therapy for heart failure: focus on natriuretic peptides
Kirkwood F. Adams et al.
HEART FAILURE REVIEWS (2010)
A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure
Runlin Gao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Biomarker-Guided Treatment of Heart Failure Still Waiting for a Definitive Answer
Richard W. Troughton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Management of Chronic Heart Failure Guided by Individual N-Terminal Pro-B-Type Natriuretic Peptide Targets Results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) Study
Luc W. M. Eurlings et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Troponin Elevation in Heart Failure Prevalence, Mechanisms, and Clinical Implications
Robb D. Kociol et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Serum Soluble ST2 A Potential Novel Mediator in Left Ventricular and Infarct Remodeling After Acute Myocardial Infarction
Robin A. P. Weir et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Soluble ST2 Monitoring Provides Additional Risk Stratification for Outpatients With Decompensated Heart Failure
Antoni Bayes-Genis et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2010)
Use of Multiple Biomarkers in Heart Failure
Larry A. Allen
Current Cardiology Reports (2010)
Assessing the Incremental Role of Novel and Emerging Risk Factors
Nancy R. Cook
CURRENT CARDIOVASCULAR RISK REPORTS (2010)
Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials
G. Michael Felker et al.
AMERICAN HEART JOURNAL (2009)
N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
Yun-He Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures
Nancy R. Cook et al.
ANNALS OF INTERNAL MEDICINE (2009)
Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury
Kevin Bersell et al.
CELL (2009)
Neuregulin-1β Is Associated With Disease Severity and Adverse Outcomes in Chronic Heart Failure
Bonnie Ky et al.
CIRCULATION (2009)
Criteria for Evaluation of Novel Markers of Cardiovascular Risk
Mark A. Hlatky et al.
CIRCULATION (2009)
Growth-Differentiation Factor-15 for Risk Stratification in Patients With Stable and Unstable Coronary Heart Disease Results From the AtheroGene Study
Tibor Kempf et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
Prognostic Value of Biomarkers in Heart Failure Application of Novel Methods in the Community
Shannon M. Dunlay et al.
CIRCULATION-HEART FAILURE (2009)
Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling
Kenjiro Seki et al.
CIRCULATION-HEART FAILURE (2009)
Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma - The Presage™ ST2 assay
Benjamin Dieplinger et al.
CLINICA CHIMICA ACTA (2009)
The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients
Yen-Hung Lin et al.
CLINICA CHIMICA ACTA (2009)
Evaluation of High-Sensitivity Assays for Cardiac Troponin
David A. Morrow et al.
CLINICAL CHEMISTRY (2009)
Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-A prospective cohort study
Anja Haase-Fielitz et al.
CRITICAL CARE MEDICINE (2009)
C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study
Adriaan A. Voors et al.
EUROPEAN HEART JOURNAL (2009)
Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy
Paul W. X. Foley et al.
EUROPEAN HEART JOURNAL (2009)
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
Arne Yndestad et al.
EUROPEAN HEART JOURNAL (2009)
Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients
Christopher Adlbrecht et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care
Urban Alehagen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Galectin-3: a novel mediator of heart failure development and progression
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
N-Terminal Pro-B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure
John G. Lainchbury et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction
Domingo A. Pascual-Figal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis
Neil C. Henderson et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage
Umesh Sharma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Assessing New Biomarkers and Predictive Models for Use in Clinical Practice A Clinician's Guide
Kevin McGeechan et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery
Beatriz Bermudez et al.
CARDIOVASCULAR RESEARCH (2008)
The Modern View of Heart Failure How Did We Get Here?
Arnold M. Katz
CIRCULATION-HEART FAILURE (2008)
Gene expression pattern in biomechanically stretched cardiomyocytes - Evidence for a stretch-specific gene program
Derk Frank et al.
HYPERTENSION (2008)
Serial Sampling of ST2 Predicts 90-Day Mortality Following Destabilized Heart Failure
Saskia Boisot et al.
JOURNAL OF CARDIAC FAILURE (2008)
Impact of myocardial function on cystatin C measurements in chronic systolic heart failure
W. H. Wilson Tang et al.
JOURNAL OF CARDIAC FAILURE (2008)
Comparison of copeptin, B-type natriuretic peptide, and amino-terminal Pro-B-type natriuretic peptide in patients with chronic heart failure
Stephanie Neuhold et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Biomarkers in heart failure
Eugene Braunwald
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure
Tibor Kempf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure
Roberto Latini et al.
CIRCULATION (2007)
Interferon-γ induces chronic active myocarditis and cardiomyopathy in transgenic mice
Kurt Reifenberg et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Serial biomarker measurements in ambulatory patients with chronic heart failure - The importance of change over time
Wayne L. Miller et al.
CIRCULATION (2007)
Arginine vasopressin increases iNOS-NO system activity in cardiac fibroblasts through NF-κB activation and its relation with myocardial fibrosis
Yan-Hong Fan et al.
LIFE SCIENCES (2007)
IL-33 and ST2 comprise a critical biomechanically induced and card ioprotective signaling system
Shoji Sanada et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction Leicester acute myocardial infarction peptide (LAMP) study
Sohail Q. Khan et al.
CIRCULATION (2007)
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure - The EVEREST clinical status trials
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effects of oral tolvaptan in patients hospitalized for worsening heart failure - The EVEREST outcome trial
Marvin A. Konstam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease - Data from the Heart and Soul Study
Joachim H. Ix et al.
CIRCULATION (2007)
Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure
B. Stoiser et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy
Xifu Liu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: The M.D. Anderson Cancer Center experience
Valentina Guarneri et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia
Kai M. Schmidt-Ott et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2006)
Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma
Jana Papassotiriou et al.
CLINICAL CHEMISTRY (2006)
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
NC Henderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The Seattle heart failure model - Prediction of survival in heart failure
WC Levy et al.
CIRCULATION (2006)
The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury
T Kempf et al.
CIRCULATION RESEARCH (2006)
Possible vascular role of increased plasma arginine vasopressin in congestive heart failure
T Nakamura et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients
J Struck et al.
PEPTIDES (2005)
Vasopressin antagonism in heart failure
SR Goldsmith et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay
NG Morgenthaler et al.
CLINICAL CHEMISTRY (2005)
Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure
T Arimoto et al.
JOURNAL OF CARDIAC FAILURE (2005)
Neurohormonal activation in congestive heart failure and the role of vasopressin
K Chatterjee
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Neuregulin receptors erbB2 and erbB4 in failing human myocardium - Depressed expression and attenuated activation
S Rohrbach et al.
BASIC RESEARCH IN CARDIOLOGY (2005)
N-terminal brain natriuretic peptide is a more powerful predictor of mortality than endothelin-1, adrenomedullin and turnour necrosis factor-α in patients referred for consideration of cardiac transplantation
RS Gardner et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Cystatin-C and mortality in elderly persons with heart failure
MG Shlipak et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure:: A 7-year follow-up study
R van Beneden et al.
JOURNAL OF CARDIAC FAILURE (2004)
Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin
J Mishra et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction
UC Sharma et al.
CIRCULATION (2004)
Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia
G Corfas et al.
NATURE NEUROSCIENCE (2004)
Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction
M Shimpo et al.
CIRCULATION (2004)
Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure
TB Horwich et al.
CIRCULATION (2003)
Identification of serum soluble ST2 receptor as a novel heart failure biomarker
EO Weinberg et al.
CIRCULATION (2003)
Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction
EO Weinberg et al.
CIRCULATION (2002)
Acute hemodynamic effects of conivaptan, a dual V1A and V2 vasopressin receptor antagonist, in patients with advanced heart failure
JE Udelson et al.
CIRCULATION (2001)
Regulation of cardiac adrenomedullin in heart failure
M Jougasaki et al.
PEPTIDES (2001)
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin - Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction
AM Richards et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism
M Sata et al.
HYPERTENSION (2000)
Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure
F Pousset et al.
EUROPEAN HEART JOURNAL (2000)
Adrenomedullin: Potential in physiology and pathophysiology
M Jougasaki et al.
LIFE SCIENCES (2000)
Share Paper
